It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The large majority of variants identified by GWAS are non-coding, motivating detailed characterization of the function of non-coding variants. Experimental methods to assess variants’ effect on gene expressions in native chromatin context via direct perturbation are low-throughput. Existing high-throughput computational predictors thus have lacked large gold standard sets of regulatory variants for training and validation. Here, we leverage a set of 14,807 putative causal eQTLs in humans obtained through statistical fine-mapping, and we use 6121 features to directly train a predictor of whether a variant modifies nearby gene expression. We call the resulting prediction the expression modifier score (EMS). We validate EMS by comparing its ability to prioritize functional variants with other major scores. We then use EMS as a prior for statistical fine-mapping of eQTLs to identify an additional 20,913 putatively causal eQTLs, and we incorporate EMS into co-localization analysis to identify 310 additional candidate genes across UK Biobank phenotypes.
Finding causal variants and genes from GWAS loci results remains a challenge. Here, the authors train a model to predict if a variant affects nearby gene expression, and apply the method to identify new possible causal eQTLs and mechanisms of GWAS loci.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Massachusetts General Hospital, Analytic and Translational Genetics Unit, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); PhD program in Bioinformatics and Integrative Genomics, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
2 Calico Life Sciences, South San Francisco, USA (GRID:grid.38142.3c)
3 Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Massachusetts General Hospital, Analytic and Translational Genetics Unit, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); PhD program in Biological and Biomedical Sciences, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
4 Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Massachusetts General Hospital, Analytic and Translational Genetics Unit, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924); PhD program in Bioinformatics and Integrative Genomics, Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Osaka University Graduate School of Medicine, Department of Statistical Genetics, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
5 Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Harvard College, Cambridge, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
6 Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34); Massachusetts General Hospital, Analytic and Translational Genetics Unit, Boston, USA (GRID:grid.32224.35) (ISNI:0000 0004 0386 9924)
7 Osaka University Graduate School of Medicine, Department of Statistical Genetics, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University, Laboratory of Statistical Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971); Osaka University, Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
8 The University of Tokyo, Laboratory of Genome Technology, Human Genome Center, Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, Laboratory of Clinical Genome Sequencing, Graduate School of Frontier Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
9 The University of Tokyo, Division of Genetics, The Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
10 The University of Tokyo, Division of Clinical Genome Research, Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
11 The University of Tokyo, Division of Molecular Pathology, IMSUT Hospital Department of Internal Medicine, Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
12 The University of Tokyo, Department of Cancer Biology, Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
13 The University of Tokyo, Laboratory of Clinical Genome Sequencing, Graduate School of Frontier Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X); The University of Tokyo, Laboratory of Complex Trait Genomics, Graduate School of Frontier Sciences, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
14 The University of Tokyo, Department of Public Policy, Institute of Medical Science, Tokyo, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
15 Iwate Medical University, Department of Urology, Iwate, Japan (GRID:grid.411790.a) (ISNI:0000 0000 9613 6383)
16 Juntendo University Graduate School of Medicine, Department of Internal Medicine and Rheumatology, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738)
17 Juntendo University Graduate School of Medicine, Department of Respiratory Medicine, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738)
18 Nihon University School of Medicine, Division of Pharmacology, Department of Biomedical Science, Tokyo, Japan (GRID:grid.260969.2) (ISNI:0000 0001 2149 8846); Nihon University. School of Medicine, Division of Genomic Epidemiology and Clinical Trials, Clinical Trials Research Center, Tokyo, Japan (GRID:grid.260969.2) (ISNI:0000 0001 2149 8846)
19 Nihon University School of Medicine, Division of Genomic Epidemiology and Clinical Trials, Clinical Trials Research Center, Tokyo, Japan (GRID:grid.260969.2) (ISNI:0000 0001 2149 8846)
20 Tokushukai Group, Tokyo, Japan (GRID:grid.260969.2)
21 Departmentof Hematology, Nippon Medical School, Tokyo, Japan (GRID:grid.410821.e) (ISNI:0000 0001 2173 8328)
22 Nippon Medical School, Department of Bioregulation, Kawasaki, Japan (GRID:grid.410821.e) (ISNI:0000 0001 2173 8328)
23 Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan (GRID:grid.417092.9)
24 Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan (GRID:grid.417092.9)
25 The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan (GRID:grid.410807.a) (ISNI:0000 0001 0037 4131)
26 Shiga University of Medical Science, Center for Clinical Research and Advanced Medicine, Shiga, Japan (GRID:grid.410827.8) (ISNI:0000 0000 9747 6806)
27 Osaka International Cancer Institute, Department of General Thoracic Surgery, Osaka, Japan (GRID:grid.489169.b)
28 IIZUKA-HOSPITAL, Fukuoka, Japan (GRID:grid.413984.3)
29 National Hospital Organization Osaka National Hospital, Osaka, Japan (GRID:grid.416803.8) (ISNI:0000 0004 0377 7966)
30 Broad Institute of MIT and Harvard, Cambridge, USA (GRID:grid.66859.34)
31 Centre for Population Genomics, Garvan Institute of Medical Research, Darlinghurst, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924); Centre for Population Genomics, Murdoch Children’s Research Institute, Parkville, Australia (GRID:grid.1058.c) (ISNI:0000 0000 9442 535X)